Deep Learning in Genomic Sequencing: Advanced Algorithms for HIV/AIDS Strain Prediction and Drug Resistance Analysis

Genome sequencing has significantly improved the understanding of HIV and AIDS through accurate data on viral transmission, evolution and anti-therapeutic processes. Deep learning algorithms, like the Fined-Tuned Gradient Descent Fused Multi-Kernal Convolutional Neural Network (FGD-MCNN), can predict strain behaviour and evaluate complex patterns. Using genotypic-phenotypic data obtained from the Stanford University HIV Drug Resistance Database, the FGD-MCNN created three files covering various antiretroviral medications for HIV predictions and drug resistance. These files include PIs, NRTIs and NNRTIs. FGD-MCNNs classify genetic sequences as vulnerable or resistant to antiretroviral drugs by analyzing chromosomal information and identifying variants. A patient's HIV strain can be classified as susceptible or resistant to 17 different treatments. The FGD-MCNN transforms DNA genotype and HIV data into mathematical metrics, providing valuable insights into treatment-resistant HIV strains through pooling analysis. With remarkable accuracy, the FGD-MCNN deep learning system predicts HIV medication resistance using behavioral and genome-wide data from the HIV database. DNA patterns can be classified as resistant or susceptible by 17 antiretroviral drugs, providing valuable information for treatment planning and medical judgment. The model's parameter values illustrate the connections between neurons and the complex webs observed in the data have been examined. This study improves treatment effectiveness and expands the knowledge of HIV/AIDS.